Cardiac Arrhythmia

Cardiac Arrhythmia

The heart's rhythm depends on ion gradients maintained across cardiac cell membranes, principally of potassium, sodium, calcium and magnesium. An arrhythmia is any departure from the normal sequence of that electrical activity, and the term covers findings of very different consequence. Premature ventricular contractions are detectable in about 75 percent of healthy adults and are usually of no clinical importance. Atrial fibrillation, which affects roughly 33.5 million people worldwide, carries a materially different risk profile.

Four ingredients are graded against rhythm endpoints in this collection, across 32 studies and 11,100 participants. The pattern of those grades is worth reading closely, because it is the one cardiovascular condition here where the largest evidence base returns the least confident direction.

Omega-3 fatty acids hold Grade B on 15 studies and 10,000 participants, and their recorded direction is mixed. The reason is that omega-3 supplementation has been associated with divergent effects depending on the rhythm in question and the dose used, a tension visible across the cardiovascular literature on these fatty acids ^[1]. A mixed grade of this kind is not an absence of data. It is a substantial body of data that does not point consistently in one direction.

Magnesium holds Grade B on 8 studies and 500 participants, with a positive direction. Its plausibility rests on established electrophysiology: magnesium is a cofactor for the sodium-potassium ATPase and modulates several potassium currents, and depletion shortens the refractory period. Much of the clinical work has concerned the specific setting of atrial fibrillation following cardiac surgery, where the exposure is short, monitored and measurable ^[2].

Potassium is graded C on 5 studies and 300 participants. The interest is mechanistic rather than nutritional: serum potassium sets the resting membrane potential, and controlled elevation within the normal range has been examined for its effect on repolarisation in long QT syndrome ^[3]. This is also the ingredient on the page where the case for caution is strongest. Potassium has a narrow therapeutic window; hyperkalaemia is itself arrhythmogenic, and the risk concentrates in people with impaired renal clearance, whose outcomes have been documented in population cohorts of chronic kidney disease ^[4]. Coenzyme Q10 completes the set at Grade C on 4 studies and 300 participants.

The listed risk factors point away from supplementation for most cases. Hypertension, coronary artery disease and heart failure are structural contributors. Thyroid disorders alter the electrical substrate systemically. Caffeine and alcohol excess, sleep apnea and electrolyte disturbance are provocations that are modifiable without a supplement. Palpitations, dizziness, syncope or chest discomfort in combination are signs that belong in a clinical assessment rather than in a supplement regimen, since the distinction between benign ectopy and a consequential rhythm requires an electrocardiogram to establish.